Overall Status

Completed (64)

Recruiting (6)

Unknown status (4)

Enrolling by invitation (1)

Not yet recruiting (1)

Terminated (1)

Withdrawn (1)

Phase

phase 1 (24)

phase 4 (24)

n/a (9)

phase 3 (8)

phase 2 (1)

phase 2/phase 3 (1)

Study Documents

CSR Snyopsis (1)

Individual Participant Data Set (1)

Manual of Procedures (1)

Study Forms (1)

Study Protocol (1)

Intervention Type

drug (73)

other (3)

behavioral (2)

procedure (2)

combination product (1)

dietary supplement (1)

Funder Type

Industry (49)

Other (27)

NIH (2)

Study Type

Interventional (67)

Observational (11)

repaglinide

Showing 76 - 78 of 78

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Diabetes, Type 2 Trial in Gentofte (Metformin, Repaglinide, Placebo-Metformin.)

Completed

Diabetes Mellitus, Type 2

Metformin
+4 more

Gentofte, Denmark

Steno Diabetes Center

Dec 5, 2008

Diabetes, Type 2 Trial in Gentofte (Metformin, Insulin BIAsp30 (Novolog 70/30), Repaglinide)

Completed

Diabetes Mellitus, Type 2

Metformin
+4 more

Gentofte, Denmark

Steno Diabetes Center

Dec 5, 2008

Diabetes, Type 2 Trial in Tainan (Repaglinide)

Unknown status

Diabetes Mellitus, Type 2

Repaglinide

Tainan, Taiwan
+1 more

Jun 12, 2006